Cargando…
Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Science Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276313/ https://www.ncbi.nlm.nih.gov/pubmed/32547605 http://dx.doi.org/10.11909/j.issn.1671-5411.2020.05.001 |
| _version_ | 1783542929725325312 |
|---|---|
| author | Han, Ya-Ling Li, Yu-Ming Ma, Chang-Sheng |
| author_facet | Han, Ya-Ling Li, Yu-Ming Ma, Chang-Sheng |
| author_sort | Han, Ya-Ling |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7276313 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Science Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72763132020-06-15 Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19 Han, Ya-Ling Li, Yu-Ming Ma, Chang-Sheng J Geriatr Cardiol Na Science Press 2020-05 /pmc/articles/PMC7276313/ /pubmed/32547605 http://dx.doi.org/10.11909/j.issn.1671-5411.2020.05.001 Text en Institute of Geriatric Cardiology http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission. |
| spellingShingle | Na Han, Ya-Ling Li, Yu-Ming Ma, Chang-Sheng Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19 |
| title | Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19 |
| title_full | Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19 |
| title_fullStr | Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19 |
| title_full_unstemmed | Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19 |
| title_short | Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19 |
| title_sort | scientific statement of the chinese society of cardiology (csc) on using of renin angiotensin system blockers in patients with cardiovascular disease and covid-19 |
| topic | Na |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276313/ https://www.ncbi.nlm.nih.gov/pubmed/32547605 http://dx.doi.org/10.11909/j.issn.1671-5411.2020.05.001 |
| work_keys_str_mv | AT hanyaling scientificstatementofthechinesesocietyofcardiologycsconusingofreninangiotensinsystemblockersinpatientswithcardiovasculardiseaseandcovid19 AT liyuming scientificstatementofthechinesesocietyofcardiologycsconusingofreninangiotensinsystemblockersinpatientswithcardiovasculardiseaseandcovid19 AT machangsheng scientificstatementofthechinesesocietyofcardiologycsconusingofreninangiotensinsystemblockersinpatientswithcardiovasculardiseaseandcovid19 |